title: Drugs can reduce the incidence of breast cancer: now what?
authors.forename: T F
authors.initials: TF
authors.lastname: Wozniak
authors.forename: P G
authors.initials: PG
authors.lastname: Eppes
authors.forename: C T
authors.initials: CT
authors.lastname: Wilson
mesh_terms: D000328:Adult; D000368:Aged; D001943:Breast Neoplasms / Q000453:epidemiology / Q000517:prevention & control*; D005260:Female; D006801:Humans; D008875:Middle Aged; D010024:Osteoporosis / Q000517:prevention & control; D017698:Postmenopause; D017697:Premenopause; D020849:Raloxifene Hydrochloride / Q000009:adverse effects / Q000627:therapeutic use*; D012307:Risk Factors; D020845:Selective Estrogen Receptor Modulators / Q000009:adverse effects / Q000627:therapeutic use*; D013629:Tamoxifen / Q000009:adverse effects / Q000627:therapeutic use*; D014594:Uterine Neoplasms / Q000139:chemically induced
chemical_list: D020845:Selective Estrogen Receptor Modulators; D013629:Tamoxifen; D020849:Raloxifene Hydrochloride